Type 1 diabetes: New cell therapy reduces need for insulin
Share on Pinterest The FDA has approved islet cellular therapy for type 1 diabetes for the first time. Image credit: Catherine Falls Commercial/Getty Images In 2021, about 8.4 million people globally had type 1 diabetes. There is currently no cure for type 1 diabetes and those with the condition have to provide their body with missing insulin for their entire life. The Food and Drug Administration (FDA) recently approved a new therapy for type 1 diabetes called Lantidra. Studies show after receiving Lantidra, some study participants did not need to administer insulin for more than 5 years. As of 2021, about 8.4 million people around the world live with type 1 diabetes — a chronic disease where the pancreas is not able to produce enough insulin for the body to function correctly. Currently, there is no cure for type 1 diabetes. The main treatment for type 1 diabetes is providing missing insulin through injections or a pump. Additionally, people with type 1 diabetes may be prescribed ad...